Distalmotion

Swiss surgical robotics company selling the DEXTER robotic surgery system and expanding its US ambulatory surgery centre business.

View on the globe

$150MEquity raised in 2025–20262025 $150M · 2026 — · 2 equity rounds
$150MEquity raised, all time2 equity rounds sourced so far
—Latest valuationnot disclosed
$70MDebt financingnot counted as equity · all in 2025–2026

Rounds over time log-scaled amounts

Funding history: 3 rounds from 18 Nov 2025 to 21 Oct 2026, $150M equity disclosed, plus $70M debt or secondary, 1 undisclosed. Earlier rounds exist but are not sourced.18 Nov 2025: Series G, $150M; 13 Jan 2026: Strategic investment, undisclosed amount; 21 Oct 2026: Term loan facility (debt, not equity), $70M$1M$3M$10M$30M$100M$300MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedQ42026Q2Q3Q42027Equity roundDebt / secondaryUndisclosed18 Nov 2025 · Series G · $150M · led by Revival Healthcare Capital21 Oct 2026 · Term loan facility (debt, not counted as equity) · $70M · led by Perceptive Advisorsn/d13 Jan 2026 · Strategic investment · amount undisclosedStrategicSeries G · $150MDebt · $70M
Funding history: 3 rounds from 18 Nov 2025 to 21 Oct 2026, $150M equity disclosed, plus $70M debt or secondary, 1 undisclosed. Earlier rounds exist but are not sourced.18 Nov 2025: Series G, $150M; 13 Jan 2026: Strategic investment, undisclosed amount; 21 Oct 2026: Term loan facility (debt, not equity), $70M$1M$3M$10M$30M$100M$300MEarlier rounds exist but are not sourced yetearlier rounds not sourced2026Q2Q3Q42027Equity roundDebt / secondaryUndisclosed18 Nov 2025 · Series G · $150M · led by Revival Healthcare Capital21 Oct 2026 · Term loan facility (debt, not counted as equity) · $70M · led by Perceptive Advisorsn/d13 Jan 2026 · Strategic investment · amount undisclosedStrategic$150M$70M debt

Funding history 3 rounds · 3 sources · newest first

Earlier rounds not yet sourced. Distalmotion raised before 18 Nov 2025; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Term loan facilityDebt · not equity
    Amount$70M
    Post-money—
    ✓ Confirmed
    Lead
    Perceptive Advisors
    Note
    Release body: 'a senior secured term loan facility of up to $70 million'. The $70M is a ceiling; drawn amount not stated. Debt, kept out of equity totals. tech.eu record dated 2026-10-29 not used (company date wins).
    Sources
  2. Strategic investment
    Amount—
    Post-money—
    ✓ Confirmed
    Lead
    Johnson & Johnson Innovation - JJDC
    Note
    Release body names one investor, Johnson & Johnson Innovation - JJDC, Inc (J&J's corporate venture arm). Amount not disclosed (amountUsd null); instrument and valuation not stated.
    Sources
  3. Series G
    Amount$150M
    Post-money—
    ✓ Confirmed
    Lead
    Revival Healthcare Capital
    Note
    Release body: '$150M USD financing was led by Revival Healthcare Capital and included inside investor participation' (no other investors named). Labelled Series G in the body (backlog said Series D+, not used). Valuation not stated.
    Sources
  4. Earlier rounds not yet sourced

Investors 2

  • Johnson & Johnson Innovation - JJDC1
  • Revival Healthcare Capital1

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Lenders and secondary buyers 1

  • Perceptive AdvisorsDebt · lead

Took part only in debt or secondary rounds, so they are not counted as investors and draw no links on the globe.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Distalmotion and its logo are trademarks of their owners, used here for identification only.